Action Ultragenyx Pharmaceutical - RARE

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Premium

Dernier

42,07

Prix Achat

37,07

Prix Vente

57,00

Volume échangé

833 991

41,58 Fourchette du Jour 43,72

37,02 Plage de 52 semaines 60,37

Cap du marché

3,885B

Clôture Veille

43,65

Ouverture

43,29

Dernière Transaction

Dernière heure de transaction

Volume financier

US$ 35 163 100

VWAP

42,1624

Volume moyen (3 m)

826 160

Actions en circulation

92 344 268

Rendement du Dividende

Ratio Cours sur Bénéfices

-6,40

Bénéfice par action (BPA)

-6,57

Chiffre d'affairess

434,25M

Bénéfice net

-606,64M

Ultragenyx Pharmaceutical Inc is a US-based biopharmaceutical company. It identifies, acquires, develops, and commercialize novel products for the treatment of serious rare and ultra-rare diseases, with the focus on serious, debilitating genetic diseases. The company's medicine portfolio includes Cr... Ultragenyx Pharmaceutical Inc is a US-based biopharmaceutical company. It identifies, acquires, develops, and commercialize novel products for the treatment of serious rare and ultra-rare diseases, with the focus on serious, debilitating genetic diseases. The company's medicine portfolio includes Crysvita and Mepsevii. Crysvita is indicated for the treatment of X-linked hypophosphatemia (XLH) in adult and pediatric patients 1 year of age and older. Show more

Secteur

Pharmaceutical Preparations

Industrie

Pharmaceutical Preparations

Site Web

www.ultragenyx.com

Siège social

Wilmington, Delaware, USA

Fondé

Ultragenyx Pharmaceutical Inc est coté dans le secteur Pharmaceutical Preparations de la NASDAQ avec le ticker RARE. Le dernier cours de clôture d'Ultragenyx Pharmaceutical était de US$43,65. Au cours de la dernière année, les actions de Ultragenyx Pharmaceutical ont été négociées dans une fourchette de prix de US$ 37,02 à US$ 60,37.

Ultragenyx Pharmaceutical compte actuellement 92 344 268 actions en circulation. La capitalisation boursière d'Ultragenyx Pharmaceutical est de US$4,03 milliard. Ultragenyx Pharmaceutical a un ratio cours/bénéfice (ratio PE) de -6.40.

Flux global

Haussier

Prime nette

548k

Calls / Puts

100,00%

Ach. / Vent.

100,00%

OTM / ITM

100,00%

Sweeps Ratio

0,00%

Ultragenyx to Present at the 43rd Annual J.P. Morgan Healthcare Conference

NOVATO, Calif., Jan. 06, 2025 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies...

Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

NOVATO, Calif., Dec. 20, 2024 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies...

Form 8-K - Current report

Ultragenyx Announces First Patient Dosed in Pivotal Phase 3 Aspire Study Evaluating GTX-102 in Angelman Syndrome

NOVATO, Calif., Dec. 19, 2024 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), today announced that the first patient has been dosed in the pivotal Phase 3 Aspire study...

Form 8-K - Current report

Ultragenyx Submits Biologics License Application to the U.S. FDA for UX111 AAV Gene Therapy for the Treatment of Sanfilippo Syndrome Type A (MPS IIIA)

NOVATO, Calif., Dec. 19, 2024 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) today announced the submission of a Biologics License Application (BLA) to the U.S. Food and Drug...

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0.92	2.23572296476	41.15	46.24	41.06	1290214	42.84499948	CS
4	-4.6	-9.8564388258	46.67	47.12	40.05	1014279	43.28140048	CS
12	-14.74	-25.9461362436	56.81	57.09	40.05	826160	47.21763315	CS
26	-0.29	-0.684608120869	42.36	60.37	40.05	754805	49.76940956	CS
52	-6.38	-13.1682146543	48.45	60.37	37.02	779830	46.94744453	CS
156	-30.15	-41.7474383827	72.22	85.53	31.52	707665	46.49741864	CS
260	-6.84	-13.9848701697	48.91	179.647	31.52	617541	60.3988225	CS

RARE - Frequently Asked Questions (FAQ)

What is the current Ultragenyx Pharmaceutical share price?

The current share price of Ultragenyx Pharmaceutical is US$ 42,07

How many Ultragenyx Pharmaceutical shares are in issue?

Ultragenyx Pharmaceutical has 92 344 268 shares in issue

What is the market cap of Ultragenyx Pharmaceutical?

The market capitalisation of Ultragenyx Pharmaceutical is USD 4,03B

What is the 1 year trading range for Ultragenyx Pharmaceutical share price?

Ultragenyx Pharmaceutical has traded in the range of US$ 37,02 to US$ 60,37 during the past year

What is the PE ratio of Ultragenyx Pharmaceutical?

The price to earnings ratio of Ultragenyx Pharmaceutical is -6,4

What is the cash to sales ratio of Ultragenyx Pharmaceutical?

The cash to sales ratio of Ultragenyx Pharmaceutical is 8,95

What is the reporting currency for Ultragenyx Pharmaceutical?

Ultragenyx Pharmaceutical reports financial results in USD

What is the latest annual turnover for Ultragenyx Pharmaceutical?

The latest annual turnover of Ultragenyx Pharmaceutical is USD 434,25M

What is the latest annual profit for Ultragenyx Pharmaceutical?

The latest annual profit of Ultragenyx Pharmaceutical is USD -606,64M

What is the registered address of Ultragenyx Pharmaceutical?

The registered address for Ultragenyx Pharmaceutical is CORPORATION TRUST CENTER, 1209 ORANGE ST, WILMINGTON, DELAWARE, 19801

What is the Ultragenyx Pharmaceutical website address?

The website address for Ultragenyx Pharmaceutical is www.ultragenyx.com

Which industry sector does Ultragenyx Pharmaceutical operate in?

Ultragenyx Pharmaceutical operates in the PHARMACEUTICAL PREPARATIONS sector

Volume
% Gagnants
% Perdants

Symbole	Prix	Vol.
VRMEVerifyMe Inc	US$ 2,57 (52,98%)	57,83M
WKEYWISeKey International Holdings AG	US$ 10,041 (52,83%)	6,72M
DATSDatChat Inc	US$ 4,8105 (49,86%)	158,65M
CDTConduit Pharmaceuticals Inc	US$ 0,1214 (48,05%)	1,17B
INTZIntrusion Inc	US$ 2,8888 (44,44%)	40,61M
IGMSIGM Biosciences Inc	US$ 2,095 (-66,21%)	5,81M
CDTGCDT Environmental Technology Investment Holdings Ltd	US$ 1,87 (-51,30%)	2,28M
MODVModivCare Inc	US$ 6,51 (-47,88%)	2,73M
AIFUAIX Inc	US$ 0,420501 (-47,76%)	7,85M
MRSNMersana Therapeutics Inc	US$ 0,691 (-46,85%)	58,44M
CDTConduit Pharmaceuticals Inc	US$ 0,1214 (48,05%)	1,17B
NVDANVIDIA Corporation	US$ 135,91 (-3,00%)	207,53M
RGTIRigetti Computing Inc	US$ 8,9299 (-11,06%)	178,82M
VMARVision Marine Technologies Inc	US$ 2,14 (40,79%)	175,57M
DATSDatChat Inc	US$ 4,8105 (49,86%)	158,65M

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Ultragenyx Pharmaceutical Inc (RARE) Cours

Ultragenyx Pharmaceutical Inc (RARE)

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Statistiques et détails clés

À propos de Ultragenyx Pharmaceutical Inc

Flux d'options Ultragenyx Pharmaceutical (RARE)

Flux global

Haussier

Prime nette

548k

Calls / Puts

100,00%

Ach. / Vent.

100,00%

OTM / ITM

100,00%

Sweeps Ratio

0,00%

RARE Dernières nouvelles

RARE - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application